Literature DB >> 22367208

Targeted gene inactivation of calpain-1 suppresses cortical degeneration due to traumatic brain injury and neuronal apoptosis induced by oxidative stress.

Kaori H Yamada1, Dorothy A Kozlowski, Stacey E Seidl, Steven Lance, Adam J Wieschhaus, Premanand Sundivakkam, Chinnaswamy Tiruppathi, Imran Chishti, Ira M Herman, Shafi M Kuchay, Athar H Chishti.   

Abstract

Calpains are calcium-regulated cysteine proteases that have been implicated in the regulation of cell death pathways. Here, we used our calpain-1 null mouse model to evaluate the function of calpain-1 in neural degeneration following a rodent model of traumatic brain injury. In vivo, calpain-1 null mice show significantly less neural degeneration and apoptosis and a smaller contusion 3 days post-injury than wild type littermates. Protection from traumatic brain injury corroborated with the resistance of calpain-1 neurons to apoptosis induced by oxidative stress. Biochemical analysis revealed that caspase-3 activation, extracellular calcium entry, mitochondrial membrane permeability, and release of apoptosis-inducing factor from mitochondria are partially blocked in the calpain-1 null neurons. These findings suggest that the calpain-1 knock-out mice may serve as a useful model system for neuronal protection and apoptosis in traumatic brain injury and other neurodegenerative disorders in which oxidative stress plays a role.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22367208      PMCID: PMC3339949          DOI: 10.1074/jbc.M111.302612

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

Review 1.  Apoptosis in neurodegenerative disorders.

Authors:  M P Mattson
Journal:  Nat Rev Mol Cell Biol       Date:  2000-11       Impact factor: 94.444

2.  Bid is cleaved by calpain to an active fragment in vitro and during myocardial ischemia/reperfusion.

Authors:  M Chen; H He; S Zhan; S Krajewski; J C Reed; R A Gottlieb
Journal:  J Biol Chem       Date:  2001-06-12       Impact factor: 5.157

3.  N-terminal cleavage of bax by calpain generates a potent proapoptotic 18-kDa fragment that promotes bcl-2-independent cytochrome C release and apoptotic cell death.

Authors:  G Gao; Q P Dou
Journal:  J Cell Biochem       Date:  2000-09-18       Impact factor: 4.429

4.  Disruption of the mouse mu-calpain gene reveals an essential role in platelet function.

Authors:  M Azam; S S Andrabi; K E Sahr; L Kamath; A Kuliopulos; A H Chishti
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

5.  Behavioral efficacy of posttraumatic calpain inhibition is not accompanied by reduced spectrin proteolysis, cortical lesion, or apoptosis.

Authors:  K E Saatman; C Zhang; R T Bartus; T K McIntosh
Journal:  J Cereb Blood Flow Metab       Date:  2000-01       Impact factor: 6.200

6.  The novel calpain inhibitor SJA6017 improves functional outcome after delayed administration in a mouse model of diffuse brain injury.

Authors:  N C Kupina; R Nath; E E Bernath; J Inoue; A Mitsuyoshi; P W Yuen; K K Wang; E D Hall
Journal:  J Neurotrauma       Date:  2001-11       Impact factor: 5.269

7.  Calpain inhibitors prevent nitric oxide-triggered excitotoxic apoptosis.

Authors:  C Volbracht; E Fava; M Leist; P Nicotera
Journal:  Neuroreport       Date:  2001-12-04       Impact factor: 1.837

8.  Differential expression of apoptotic protease-activating factor-1 and caspase-3 genes and susceptibility to apoptosis during brain development and after traumatic brain injury.

Authors:  A G Yakovlev; K Ota; G Wang; V Movsesyan; W L Bao; K Yoshihara; A I Faden
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

Review 9.  Ca2+ dysfunction in neurodegenerative disorders: Alzheimer's disease.

Authors:  Laura Fedrizzi; Ernesto Carafoli
Journal:  Biofactors       Date:  2011 May-Jun       Impact factor: 6.113

10.  Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis.

Authors:  T Nakagawa; J Yuan
Journal:  J Cell Biol       Date:  2000-08-21       Impact factor: 10.539

View more
  28 in total

1.  Calpain-1 knockout reveals broad effects on erythrocyte deformability and physiology.

Authors:  Adam Wieschhaus; Anwar Khan; Asma Zaidi; Henry Rogalin; Toshihiko Hanada; Fei Liu; Lucia De Franceschi; Carlo Brugnara; Alicia Rivera; Athar H Chishti
Journal:  Biochem J       Date:  2012-11-15       Impact factor: 3.857

2.  The Long-Term Impairment in Redox Homeostasis Observed in the Hippocampus of Rats Subjected to Global Perinatal Asphyxia (PA) Implies Changes in Glutathione-Dependent Antioxidant Enzymes and TIGAR-Dependent Shift Towards the Pentose Phosphate Pathways: Effect of Nicotinamide.

Authors:  C Lespay-Rebolledo; A Tapia-Bustos; D Bustamante; P Morales; M Herrera-Marschitz
Journal:  Neurotox Res       Date:  2019-06-11       Impact factor: 3.911

Review 3.  Neuronal Cell Death.

Authors:  Michael Fricker; Aviva M Tolkovsky; Vilmante Borutaite; Michael Coleman; Guy C Brown
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

4.  Protection against TBI-Induced Neuronal Death with Post-Treatment with a Selective Calpain-2 Inhibitor in Mice.

Authors:  Yubin Wang; Yan Liu; Dulce Lopez; Moses Lee; Sujay Dayal; Alexander Hurtado; Xiaoning Bi; Michel Baudry
Journal:  J Neurotrauma       Date:  2017-08-18       Impact factor: 5.269

Review 5.  Cell Death and Recovery in Traumatic Brain Injury.

Authors:  Yosuke Akamatsu; Khalid A Hanafy
Journal:  Neurotherapeutics       Date:  2020-04       Impact factor: 7.620

Review 6.  Oxidative stress, DNA damage, and the telomeric complex as therapeutic targets in acute neurodegeneration.

Authors:  Joshua A Smith; Sookyoung Park; James S Krause; Naren L Banik
Journal:  Neurochem Int       Date:  2013-02-17       Impact factor: 3.921

7.  Targeting the nNOS/peroxynitrite/calpain system to confer neuroprotection and aid functional recovery in a mouse model of TBI.

Authors:  Mushfiquddin Khan; Tajinder S Dhammu; Fumiyo Matsuda; Balasubramaniam Annamalai; Tejbir Singh Dhindsa; Inderjit Singh; Avtar K Singh
Journal:  Brain Res       Date:  2015-11-17       Impact factor: 3.252

8.  Calpain-1 ablation partially rescues disease-associated hallmarks in models of Machado-Joseph disease.

Authors:  Jonasz J Weber; Eva Haas; Yacine Maringer; Stefan Hauser; Nicolas L P Casadei; Athar H Chishti; Olaf Riess; Jeannette Hübener-Schmid
Journal:  Hum Mol Genet       Date:  2020-04-15       Impact factor: 6.150

9.  Gene Profiling of Nucleus Basalis Tau Containing Neurons in Chronic Traumatic Encephalopathy: A Chronic Effects of Neurotrauma Consortium Study.

Authors:  Elliott J Mufson; Bin He; Stephen D Ginsberg; Benjamin A Carper; Gayle S Bieler; Fiona Crawford; Victor E Alvarez; Bertrand R Huber; Thor D Stein; Ann C McKee; Sylvia E Perez
Journal:  J Neurotrauma       Date:  2018-04-05       Impact factor: 5.269

10.  The cysteine protease cathepsin B is a key drug target and cysteine protease inhibitors are potential therapeutics for traumatic brain injury.

Authors:  Gregory R Hook; Jin Yu; Nancy Sipes; Michael D Pierschbacher; Vivian Hook; Mark S Kindy
Journal:  J Neurotrauma       Date:  2014-02-06       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.